| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/21/2005 | US20050084527 Pharmaceutical formulations containing combinations of epinastine, pseudoephedrine, and methylephedrine |
| 04/21/2005 | US20050084505 Utilization of ubiquinones for influencing the effect of histamine |
| 04/21/2005 | US20050084489 Synergistic administration of Vitaxin, a FAB fragment, or a competitive binding antibody for binding integrin alpha V beta 3 with the enzyme inhibitor; antiinflammatory, anticarcinogenic agents; autoimmune and metabolic bone disorders |
| 04/21/2005 | US20050084463 Antiinflammatory, antiarthritic agents, analgesics for pain caused by diabetic assoicated conditions, pneumoconiosis, angina, menstruation or cancer |
| 04/21/2005 | CA2538104A1 Use of xenon with hypothermia for treating neonatal asphyxia |
| 04/20/2005 | EP1523988A1 A composition containing radix codonopsis pilosulae and radix astragali and hedysari, method of producing it and use thereof |
| 04/20/2005 | EP1523976A2 Pharmaceutical formulations of salmeterol |
| 04/20/2005 | EP1523556A1 Methods of treating conditions associated with an edg-1 receptor |
| 04/20/2005 | EP1523488A1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 04/20/2005 | EP1523480A2 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use |
| 04/20/2005 | EP1523471A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 04/20/2005 | EP1523323A2 Reagents and methods for smooth muscle therapies |
| 04/20/2005 | EP1373249B1 Imidazolidine derivatives, their preparation, and their use as antiinflamatory agent |
| 04/20/2005 | EP1349847B1 Oxybenzamides derivatives as factor xa inhibitors |
| 04/20/2005 | EP1252158B1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 04/20/2005 | EP1226110B1 Bicyclic amino acids as pharmaceutical agents |
| 04/20/2005 | EP1135117B1 Medikament for treating chronic obstructive pulmonary disease |
| 04/20/2005 | EP1015431B1 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 04/20/2005 | EP0805859B1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses |
| 04/20/2005 | EP0775213B1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 04/20/2005 | CN1608067A Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 04/20/2005 | CN1608065A Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase and pharmaceutical compositions containing the compounds |
| 04/20/2005 | CN1608064A Novel compounds |
| 04/20/2005 | CN1608062A Salt forms of e-2-methoxy-n-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 04/20/2005 | CN1608060A Diaryl 1, 2, 4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/20/2005 | CN1608059A Bipyridyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/20/2005 | CN1607960A Glycoprotein compositions |
| 04/20/2005 | CN1607945A Composite dosage forms with a coating portion |
| 04/20/2005 | CN1607940A Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
| 04/20/2005 | CN1607207A S protein of SARS virus, its vaccine and method for screening medicament using it |
| 04/20/2005 | CN1606993A Nanometer compound Chinese medicinal formulation for treating chronic atrophic gastritis and its preparing method |
| 04/20/2005 | CN1606980A Novel levamisole formulation for chronic rhinitis |
| 04/20/2005 | CN1197595C Chinese medicine preparation for broad-spectrum inflammation relieving, disinfecting, erosion prevention and muscle growing |
| 04/20/2005 | CN1197580C Medicine containing fritillary total alkali for treating disease of respiratory system and its preparing method |
| 04/20/2005 | CN1197579C Composition for curing bronchial asthma |
| 04/20/2005 | CN1197557C Constant speed release terbutaline controlled releasing preparation |
| 04/20/2005 | CN1197541C Two chamber cartridge for atomizers |
| 04/19/2005 | US6881857 Tricyclic diterpene derivatives |
| 04/19/2005 | US6881755 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 04/19/2005 | US6881754 Adamantane derivatives |
| 04/19/2005 | US6881740 Pharmaceutical agents |
| 04/19/2005 | US6881739 Use of cortisol antagonists in the treatment of heart failure |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/19/2005 | US6881730 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 04/19/2005 | US6881422 Drug for respiratory system disorders |
| 04/19/2005 | CA2273894C Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use |
| 04/14/2005 | WO2005032540A1 Remedy for respiratory diseases comprising n-(benzoyl)amino acid derivative as the active ingredient |
| 04/14/2005 | WO2005005424B1 Aztreonam l-lysine and methods for the preparation thereof |
| 04/14/2005 | WO2005000815A3 Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic m3 receptor |
| 04/14/2005 | US20050080266 Nitrogen compounds such as 8,9-dihydroxy-1,2,3,11b-tetrahydro-chromeno(4,3,2-de)isoquinoline hydrobromide, administered for prophylaxis of nervous system disorders |
| 04/14/2005 | US20050080233 Expression vector comprising nucleotide sequences coding bacterial outer membrane protein for use in diagnosis, prevention and treatment of microorganismal infection |
| 04/14/2005 | US20050080117 Substituted benzoxazoles as estrogenic agents |
| 04/14/2005 | US20050080107 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates |
| 04/14/2005 | US20050080104 Preparing 3-[(4S)-5-oxo-2-(trifluoromethyl)-1,4,5,6,7,8-hexahydroquinolin-4-yl]benzonitrile by reacting an ester of 4,4,4-trifluoro-3-oxobutanoate with 1,3-cyclohexanedione and 3-cyanobenzaldehyde, , dehydrating and de-esterifying the intermeidate |
| 04/14/2005 | US20050080097 5-[1-(hydroxymethyl)propyl]amino-7-benzylamino-3-isopropyl(methyl, ethyl)pyrazolo[4,3-d]pyrimidine for inhibiting cell proliferation, cancer, or psoriasis, rheumatoid arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, and neurodegerative diseases |
| 04/14/2005 | US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators |
| 04/14/2005 | US20050080067 Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 04/14/2005 | US20050080029 Administering to the cell the compound to be delivered, an organic halide, and/or a carrier; ultrasound may also be applied |
| 04/14/2005 | US20050080026 Nucleic acid molecule of MAP kinase interacting kinase gene family or polypeptide encoded thereby or fragment or variant of nucleic acid molecule, polypeptide or antibody, aptamer or receptor recognizing a nucleic acid molecule of gene family or polypeptide encoded thereby; treating metabolic diseases |
| 04/14/2005 | US20050079495 Modified membrane protein comprising proteolytic and is absent for g-protein coupling for use as tool in diagnosis, prevention and treatment of pain, arthritis, asthma, psychological and gastrointestinal disorders |
| 04/14/2005 | US20050079176 Treating stress response with chemokine receptor ccr5 modulators |
| 04/14/2005 | US20050079175 Administering receptor ligand protein suspension to prevent binding to lymphocytes |
| 04/14/2005 | US20050079136 Therapy for pain, appetite inttensifiers, multiple sclerosis and asthma; drug delivery |
| 04/14/2005 | DE10345343A1 Production of an ivy leaf extract with both rapid and prolonged action in treating respiratory diseases, comprises mixing a first ivy extract rich in hederacoside C with a second ivy extract rich in alpha-hederin |
| 04/13/2005 | EP1521824A2 Nucleic acid-associated proteins |
| 04/13/2005 | EP1521764A2 New compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 04/13/2005 | EP1521763A2 Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 04/13/2005 | EP1521757A1 Novel tricyclic spiropiperidines or spiropyrrolidines |
| 04/13/2005 | EP1521740A2 Probucol derivatives |
| 04/13/2005 | EP1521735A2 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 04/13/2005 | EP1521733A1 Modulators of the glucocorticoid receptor |
| 04/13/2005 | EP1521595A1 Novel drug compositions based on novel anticholinergics and inhibitors of egfr-kinase |
| 04/13/2005 | EP1521582A1 2,5-substituted pyrimidine derivatives as ccr-3 receptor antagonists |
| 04/13/2005 | EP1521580A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and nk1-receptor antagonists |
| 04/13/2005 | EP1521576A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and pde-iv inhibitors |
| 04/13/2005 | EP1366050B1 Condensed pyrazindione derivatives as pde inhibitors |
| 04/13/2005 | EP1335706B1 Process fo r the production of microspheres of pancreatic enzymes with high stability |
| 04/13/2005 | EP1289955B1 Piperidines for use as orexin receptor antagonists |
| 04/13/2005 | EP1257270B1 A method for synthesizing leflunomide |
| 04/13/2005 | EP1254104B1 Quaternary ammonium compounds and their use as anti-tussive agent |
| 04/13/2005 | EP1244641B1 Thiazolyl amide derivatives |
| 04/13/2005 | EP1183353B1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 04/13/2005 | EP1059917B1 Pharmaceutical preparation for use in anti-asthma therapy |
| 04/13/2005 | EP0975349B1 Serine proteinase inhibitory activity by hydrophobic tetracycline |
| 04/13/2005 | CN1606557A Deuterated pyrazolopyrimidinones and drugs containing said compounds |
| 04/13/2005 | CN1606556A Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 04/13/2005 | CN1606555A Imidazoquinoline derivatives |
| 04/13/2005 | CN1606554A Beta-lactamyl vasopressin v1aantagonists |
| 04/13/2005 | CN1606545A Pyrrolidine and piperidine derivates as nk1 antagonists |
| 04/13/2005 | CN1606457A Methods for sterilizing preparations containing albumin |
| 04/13/2005 | CN1606446A Method for preventing and treating communicable diseases and other diseases using monosaccharides and disaccharides |
| 04/13/2005 | CN1606444A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 04/13/2005 | CN1606440A Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic, and medicament comprising them |
| 04/13/2005 | CN1606436A Compounds and methods of treating transplant rejection |
| 04/13/2005 | CN1605355A Snuffle dredging capsule |
| 04/13/2005 | CN1605351A Preparation process and novel application of Laiyang pear buccal tablet and other oral formulation |
| 04/13/2005 | CN1605349A Chinese traditional medicine for treating cough and variable asthma after cold and its preparation |
| 04/13/2005 | CN1605332A Fibrauretine injection for perfusion and its preparing process |
| 04/13/2005 | CN1196703C Pyrazolobenzodiazepines as CDK2 inhibitors |
| 04/13/2005 | CN1196687C Inhibitors of IMPDH enzyme |